Enjoy a flat 20% OFF on all 2025 Global Market Reports until March 31st! Use code FY25SAVE to save big—don’t miss out!
How large is the spinal cord stimulation devices market, and what is its growth trajectory?
The spinal cord stimulation devices market size has grown strongly in recent years. It will grow from $2.74 billion in 2024 to $2.99 billion in 2025 at a compound annual growth rate (CAGR) of 9.01%. The growth in the historic period can be attributed to improved clinical outcomes and patient satisfaction, an increase in awareness of pain management alternatives, a rise in reimbursement support, a rise in clinical research and regulatory approvals, and growth in pain management clinics and centers.
The spinal cord stimulation devices market size is expected to see strong growth in the next few years. It will grow to $4.18 billion in 2029 at a compound annual growth rate (CAGR) of 8.75%. The growth in the forecast period can be attributed to the increasing prevalence of chronic pain conditions, rising demand for non-opioid pain management solutions, a growing geriatric population, supportive reimbursement policies, rising adoption of wireless and rechargeable devices, and increasing awareness of neuromodulation therapies among healthcare professionals and patients. Major trends in the forecast period include advancements in minimally invasive technologies, advancements in wireless and rechargeable devices, advancements in frequency stimulation, adoption of closed-loop feedback systems, integration of wireless connectivity, advanced waveform options, and personalized pain management algorithms.
Get Your Free Sample of The Global Spinal Cord Stimulation Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20964&type=smp
What are the key forces behind the spinal cord stimulation devices market’s growth in recent years?
The rise in prevalence of chronic pain cases is expected to drive the growth of the spinal cord stimulation devices market going forward. Chronic pain cases refer to persistent pain lasting for 12 weeks or more, stemming from conditions such as arthritis, neuropathy, or low back pain. The rise in chronic pain cases can be attributed to several factors, including an aging population, lifestyle changes, chronic health conditions, and injury or trauma. Spinal cord stimulation (SCS) devices alleviate chronic pain by altering pain signals with electrical impulses, providing relief for persistent conditions. For instance, in November 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, it was reported that in 2023, 24.3% of adults reported chronic pain, with 8.5% experiencing high-impact chronic pain, accounting for 34.9% of those with chronic pain. Therefore, the rise in the prevalence of chronic pain cases is driving the growth of the spinal cord stimulation devices market.
What are the major segments of the spinal cord stimulation devices market?
The spinal cord stimulation devices market covered in this report is segmented –
1) By Type: Implantable Spinal Cord Stimulators, Non-Implantable Spinal Cord Stimulators
2) By Product Type: Rechargeable Devices, Non-Rechargeable Devices
3) By Application: Failed Back Surgery Syndrome, Complex Regional Pain Syndrome, Degenerative Disc Disease, Unsuccessful Disk Surgery, Other Applications
4) By End User: Hospitals, Ambulatory Surgical Centers, Neuro Clinics
Subsegments:
1) By Implantable Spinal Cord Stimulators: Rechargeable Spinal Cord Stimulators, Non-Rechargeable Spinal Cord Stimulators, Multi-Lead Implantable Spinal Cord Stimulators
2) By Non-Implantable Spinal Cord Stimulators: External Spinal Cord Stimulators, Wearable Spinal Cord Stimulators, Transcutaneous Spinal Cord Stimulators
Order your report now for swift delivery
Which companies dominate the spinal cord stimulation devices market?
Major companies operating in the spinal cord stimulation devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Nevro Corp., Bluewind Medical, NeuroPace Inc., Vertos Medical Inc., SPR Therapeutics Inc., Saluda Medical Pty Ltd., Stimwave Technologies Inc., Nuvectra Inc., Soterix Medical Inc., Synapse Biomedical, ONWARD Medical NV, NeuroSigma Inc., Nalu Medical Inc., Neurostim Technologies, SpineX Inc., Aleva Neurotherapeutics SA, GTX Medical BV
Which key trends are expected to influence the spinal cord stimulation devices market in the coming years?
Major companies operating in the spinal cord stimulation devices market are focusing on developing advanced technologies, such as rechargeable spinal cord stimulation systems, to improve patient outcomes, enhance device longevity, and provide more personalized pain management solutions for individuals suffering from chronic pain. Rechargeable spinal cord stimulation (SCS) systems are advanced medical devices designed to manage chronic pain by delivering electrical impulses to the spinal cord. For instance, in December 2022, Abbott Laboratories, a US-based medical device manufacturing company, received the approval of the US Food and Drug Administration (FDA) for its Eterna spinal cord stimulation (SCS) system, a groundbreaking solution for chronic pain management. This innovative device combines a compact design with cutting-edge functionality, providing enhanced comfort and reduced physical burden for patients. Its rechargeable feature ensures long-term usability, minimizing the need for surgical replacements and promoting convenience. The system is equipped with precise stimulation capabilities, allowing for personalized pain relief tailored to individual patient needs. Its streamlined design facilitates minimally invasive implantation, reducing recovery time and improving overall patient outcomes.
What are the key regional dynamics of the spinal cord stimulation devices market, and which region leads in market share?
North America was the largest region in the spinal cord stimulation devices market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spinal cord stimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Spinal Cord Stimulation Devices Market Report 2025 Offer?
The spinal cord stimulation devices market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Spinal cord stimulation (SCS) devices are implantable medical devices designed to manage chronic pain by delivering mild electrical pulses to the spinal cord, disrupting pain signals before they reach the brain. These devices combine advanced neurotechnology with customizable programming, offering a minimally invasive solution for conditions such as neuropathic pain and failed back surgery syndrome.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20964
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
